Anuh Pharma

65
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE489G01022
  • NSEID: ANUHPHR
  • BSEID: 506260
INR
93.70
0.22 (0.24%)
BSENSE

Sep 21, 10:56 AM

BSE+NSE Vol: 93.16 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 16.65% vs 2.24% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 1.09% vs -18.77% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -23.13% vs 29.81% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -13.32% vs -21.16% in Mar 2025

Compare Profit and Loss Results of Anuh Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
771.00
234.00
537.00
229.49%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
771.00
234.00
537.00
229.49%
Expenditure (Ex Depriciation)
Stock Adjustments
10.00
2.00
8.00
400.00%
Raw Materials Consumed
589.00
149.00
440.00
295.30%
Power & Fuel Cost
13.00
4.00
9.00
225.00%
Employee Cost
26.00
25.00
1.00
4.00%
Operating Expenses
40.00
14.00
26.00
185.71%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
5.00
5.00
100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
11.00
4.00
7.00
175.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
709.00
212.00
497.00
234.43%
Operating Profit (PBDIT) excl Other Income
62.00
21.00
41.00
195.24%
Other Income
4.00
12.00
-8.00
-66.67%
Operating Profit (PBDIT)
66.00
33.00
33.00
100.00%
Interest
0.00
3.00
-3.00
-100.00%
Profit before Depriciation and Tax
65.00
30.00
35.00
116.67%
Depreciation
11.00
8.00
3.00
37.50%
Profit Before Taxation & Exceptional Items
54.00
21.00
33.00
157.14%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
54.00
21.00
33.00
157.14%
Provision for Tax
13.00
5.00
8.00
160.00%
Profit After Tax
41.00
16.00
25.00
156.25%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
184.00
231.00
-47.00
-20.35%
Profit Available for appropriations
225.00
247.00
-22.00
-8.91%
Appropriations
225.00
247.00
-22.00
-8.91%
Equity Dividend (%)
30%
10%
20.00
Earnings Per Share
4.1
23.24
-19.14
-82.36%
Profit And Loss - Net Sales
Net Sales 771.66 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.65% vs 2.24% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 62.20 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 1.09% vs -18.77% in Mar 2025

Profit And Loss - Interest
Interest 0.95 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -23.13% vs 29.81% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 41.05 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -13.32% vs -21.16% in Mar 2025